AG2037

GARFT inhibitor AG2037 · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AG2037, covering 2006-11-09 to 2013-12-16. Get the full timeline:

Most recent: Clinical Trial Update: AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors [Phase 1]